Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First, is scheduled to end on July 31st. Learn about your options to continue receiving care at Temple Health.
Breadcrumb
- Home
- Fox Chase Cancer Center Events
- Epigenetics Symposium: From Genes to Chromatin to Therapeutics
Epigenetics Symposium: From Genes to Chromatin to Therapeutics
Date & Time
Location
The Franklin Institute
222 N 20th St
Philadelphia, PA 19103
Registration Information
This event is complimentary but pre-registration is required. A virtual option is available for this event, please indicate if you are signing up for in-person or virtual when you register.
Schedule
Program: 8:30 AM - 5:30 PM
Reception: 5:30 PM - 7:00 PM
8:00 AM | Registration & Light Breakfast |
8:50 – 9:00 AM | Welcome by Johnathan Whetstine, PhD |
9:00 – 9:25 AM | Daniel De Carvalho, PhD – University of Toronto |
9:25 – 9:50 AM | Chuan He, PhD – University of Chicago |
9:50 – 10:15 AM | Karen Adelman, PhD – Harvard Medical School |
10:15 – 10:20 AM | Keynote Introduction |
10:20 – 11:05 AM | Robert Roeder, PhD - The Rockerfeller University |
11:05 – 11:25 AM | Break |
11:25 – 11:50 AM | Gerd Blobel, MD, PhD – Children’s Hospital of Philadelphia |
11:50 AM – 12:15 PM | Nada Jabado, MD, PhD – McGill University |
12:15 – 2:00 PM | Lunch/Poster Session |
2:00 – 2:25 PM | Jian Jin, PhD – Icahn School of Medicine at Mount Sinai |
2:25 – 2:50 PM | Yael David, PhD – Memorial Sloan Kettering Cancer Center |
2:50 – 4:10 PM | Industry Panel – Epigenetic Therapeutic Opportunities |
4:10 – 4:30 PM | Break |
4:30 – 4:55 PM | Scott Armstrong, MD, PhD – Dana-Farber Cancer Institute, Harvard |
4:55 – 5:20 PM | Anjana Rao, PhD – La Jolla Institute for Immunology |
5:20 – 5:30 PM | Closing Remarks |
Speakers
Keynote Speaker: Dr. Robert G. Roeder, The Rockefeller University
- Dr. Daniel De Carvalho, University of Toronto
- Dr. Chuan He, University of Chicago
- Dr. Karen Adelman, Harvard Medical School
- Dr. Gerd Blobel, Children’s Hospital of Philadelphia
- Dr. Nada Jabado, McGill University
- Dr. Jian Jin, Icahn School of Medicine at Mount Sinai
- Dr. Yael David, Memorial Sloan Kettering Cancer Center
- Dr. Scott Armstrong, Dana-Farber Cancer Institute, Harvard
- Dr. Anjana Rao, La Jolla Institute for Immunology
The event will also feature an afternoon speaker session with leading industry members discussing epigenetic-related therapies. Panelists include:
- AstraZeneca
- Daiichi Sankyo
- Epizyme
- Foghorn Therapeutics – “Targeting Transcription Factor-BAF interactions in Cancer” - Asad Taherbhoy, PhD
- Incyte - "Targeting BET Bromodomain Proteins for the Treatment of Cancer" - Susan Wee, PhD
- Oryzon Genomics - “Iadademstat, paving the way to new therapies in AML and SCLC” - Ana Limón, PhD
- Vyne Therapeutics
Thank You to Our Sponsors!
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Add Event to your Calendar (iOS 9 or higher recommended)iCal
Share
-
Share with Facebook
-
Share with twitter
-
Share with email
-
Print this